Cover image for Anticancer drug development guide : preclinical screening, clinical trials, and approval
Title:
Anticancer drug development guide : preclinical screening, clinical trials, and approval
Author:
Teicher, Beverly A., 1952-
ISBN:
9781588292285
Edition:
2nd ed.
Publication Information:
Totowa, N.J. : Humana Press, c2004.
Physical Description:
xiv, 450 s. : res. + 1 CD-ROM (4 3/4 in.)
Series:
Cancer drug discovery and development
Series Title:
Cancer drug discovery and development
Contents:
High-volume screening / Michel Pagè -- High-throughput screening in industry / Michael D. Boisclair ... [et al.] -- The NCI human tumor cell line (60-cell) screen: concept, implementation, and applications / Michael R. Boyd -- Human tumor screening / Axel-R. Hanauske, Susan G. Hilsenbeck, and Daniel D. Von Hoff -- Murine L1210 and P388 leukemias / William R. Waud -- In vivo methods for screening and preclinical testing: use of rodent solid tumors for drug discovery / Thomas Corbett ... [et al.] -- Human tumor xenograft models in NCI drug development / Michael C. Alley ... [et al.] -- NCI specialized procedures in preclinical drug evaluations / Melinda G. Hollingshead ... [et al.] --

Patient-like orthotopic metastatic models of human cancer / Robert M. Hoffman -- Preclinical models for combination therapy / Beverly A. Teicher -- Models for biomarkers and minimal residual tumor / Beverly A. Teicher -- Spontaneously occurring tumors in companion animals as models for drug development / David M. Vail and Douglas H. Thamm -- Nonclinical testing: from theory to practice / Denis Roy and Paul A. Andrews -- Nonclinical testing for oncology drug products / Paul A. Andrews and Denis Roy -- Nonclinical testing for oncology biologic products / Carolyn M. Laurençot, Denis Roy, and Paul A. Andrews --

Working with the national cancer institute / Paul Thambi and Edward A. Sausville -- Phase I trial design and methodology for anticancer drugs / Patrick V. Acevedo, Deborah L. Toppmeyer, and Eric H. Rubin -- Phase II trials: conventional design and novel strategies in the era of targeted therapies / Keith T. Flaherty and Peter J. O'Dwyer --

Drug development in Europe: the academic perspective / Chris Twelves ... [et al.] -- The phase III clinical cancer trial / Ramzi N. Dagher and Richard Pazdur -- Assessing tumor-related symptoms and health-related quality of life in cancer clinical trials: a regulatory perspective / Judy H. Chiao, Grant Williams, and Donna Griebel -- The role of the oncology drug advisory committee in the FDA review process for oncologic products / Leslie A. Vaccari -- FDA role in cancer drug development and requirements for approval / Susan Flamm Honig.
Holds:

Copies:

Library
Click to Sort
Material Type
Click to Sort
Item Barcode
Click to Sort
Shelf Number
Click to Sort
Status
Click to Sort
Item Holds
Click to Sort
Searching...
Book 7.2/12/397639 QV 269 A6295 2004
Searching...
Searching...
Cd-Rom C001225 QV 269 A6295 2004
Searching...